The Mets have made a move that wouldn’t help them in 2022, as they signed John Curtiss to a major league deal. Curtiss is currently rehabbing from his TJS and will miss the entire 2022 season. The Mets made this move for his cheap team option in 2023. He is signed for 770.000 this year with a 775.000 team option.
In 2022 Curtiss pitched to a 3.45 ERA after a 2.48 ERA with the Marlins, before he got hurt. In 44.1 innings, he pitched to a 3.82FIP and 1.23 WHIP. The 29 year old righty has a 2.89 ERA in 71.2 innings since 2019.
This is a very smart move by the Mets. Worst case scenario is losing close to 1.5 mil, but if the rehab goes well they added a solid reliever without spending a lot. With some prime Mets relievers in their last season before hitting free agency, this could be a very important move.
The Mets also made some other moves as they put Chasen Shreve and Travis Jankowski on the 40 man roster. Both will make the team out of spring training. To make room, the Mets DFA’d Travis Blankenhorn and Jordan Yamamoto
Photo Credit: MLB Trade Rumors
Mets Junkies 